# Systematic identification of bedaquiline-anchored regimens with cross-species efficacy for nontuberculous mycobacterial pulmonary disease

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41598-026-79568-x) · 2026-11-15 · Medicine
Page: https://themorning.science/story/systematic-identification-of-bedaquiline-anchored-regimens-with-cross-species-ef-00ba027e796c1039
Kind: research · Impact: low

## In brief

- A research article titled 'Systematic identification of bedaquiline-anchored regimens with cross-species efficacy for nontuberculous mycobacterial pulmonary disease' appeared in nature.com subject feeds.
- The provided sources include no summary, so specific findings cannot be confirmed.
- The study concerns bedaquiline-based drug regimens for nontuberculous mycobacterial pulmonary disease.

## Why it matters

The study addresses treatment regimens for nontuberculous mycobacterial lung disease, which matters to researchers and clinicians working on this condition.

## Timeline

- 2026-11-15: Article listed in nature.com subject feeds

## Coverage

- [Systematic identification of bedaquiline-anchored regimens with cross-species efficacy for nontuberculous mycobacterial pulmonary disease](https://www.nature.com/articles/s41598-026-79568-x) — Medical research : nature.com subject feeds, 2026-11-15

Tags: mycobacteria, lung-disease, bedaquiline, drug-regimens, antibiotics

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
